Alzheimer’s Drug Discovery Foundation:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9318
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alzheimer’s Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation. The foundation offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. It offers services and support for development of drugs to prevent, treat, and cure Alzheimer’s disease. ADDF provides grants to the recipients for the treatment of Alzheimer’s disease. The foundation provides funds on preclinical research and early-stage clinical trials for new drug targets. It partners with various universities, and other research and development organizations. ADDF is headquartered in New York, the US.

Alzheimer’s Drug Discovery Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
M3 Biotechnology Raises USD15.2 Million in Venture Financing 10
M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12
Partnerships 13
Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer’s Disease Drugs 13
Equity Offering 14
Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14
Alzheimer’s Drug Discovery Foundation – Key Competitors 15
Alzheimer’s Drug Discovery Foundation – Key Employees 16
Alzheimer’s Drug Discovery Foundation – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
May 10, 2018: $2.5 Million in New Funding Exemplifies ADDF’s Strategy 18
Apr 12, 2018: Inaugural Memories Matter Benefit Raises $1.2 Million for Alzheimers Drug Research 21
Mar 28, 2018: Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute Invite Applications for 2018 ADDF-Harrington Scholar Award 22
Mar 13, 2018: Funding Supports New Approaches to Treat Multiple Types of Dementia 23
Jan 09, 2018: Alzheimer’s Drug Discovery Foundation: $2.5 Million in New Grants Advance Clinical Trials of Alzheimers Treatments 24
Jan 08, 2018: Alzheimer’s Drug Discovery Foundation: $1.8 Million in New Funding Supports Clinical Stage Treatments 25
Jan 08, 2018: $1.8 Million in New Funding Supports Clinical Stage Treatments 27
Nov 14, 2017: Alzheimer’s Drug Discovery Foundation Announces Three New Grants 29
Sep 12, 2017: Three New Grants Support Promising Treatments for Alzheimers Disease 30
Sep 05, 2017: New Funding Supports Blood Test for Early Alzheimer’s 31
May 15, 2017: $2.6 Million in New Grants Spurs Innovation 32
Apr 20, 2017: ADDF-Funded Scientists Discover Two Repurposed Drugs With Promise for Alzheimers and FTD 35
Mar 07, 2017: $4 Million in New Grants Support Several First-in-class Dementia Treatments 36
Mar 01, 2017: Cypralis Announces Grant Award from Alzheimer’s Drug Discovery Foundation 39
Jan 09, 2017: $2.5 Million in New Grants Advance Clinical Trials of Alzheimer’s Treatments 40
Product News 42
Nov 01, 2017: New Report Highlights Innovation in Alzheimers Clinical Trials 42
Jun 07, 2017: The Alzheimer’s Drug Discovery Foundation and Science Exchange Launch ADDF ACCESS to Advance CNS Research 43
Other Significant Developments 44
Jun 07, 2017: ADDF and Science Exchange Launch ADDF ACCESS to Advance Research 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alzheimer's Drug Discovery Foundation, Deals By Therapy Area, 2012 to YTD 2018 8
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
M3 Biotechnology Raises USD15.2 Million in Venture Financing 10
M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12
Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer's Disease Drugs 13
Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14
Alzheimer's Drug Discovery Foundation, Key Competitors 15
Alzheimer's Drug Discovery Foundation, Key Employees 16

List of Figures
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Alzheimer’s Drug Discovery Foundation:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lyft Inc (LYFT)
    Lyft Inc (LYFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • SATCO Products Inc:企業の戦略的SWOT分析
    SATCO Products Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • China General Technology (Group) Holding Ltd:企業の戦略・SWOT・財務情報
    China General Technology (Group) Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary China General Technology (Group) Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Scholastic Corporation:企業の戦略・SWOT・財務情報
    Scholastic Corporation - Strategy, SWOT and Corporate Finance Report Summary Scholastic Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MMC Norilsk Nickel:企業のM&A・事業提携・投資動向
    MMC Norilsk Nickel - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MMC Norilsk Nickel Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • ACWA Power International:電力:M&Aディール及び事業提携情報
    Summary ACWA Power International (ACWA Power), a subsidiary of ACWA Holding is a power generation company that develops and operates power generation and desalinated water production plants. The company holds a generation portfolio of power and desalinated water. Its projects comprise in selecting i …
  • LendingClub Corporation (LC):企業の財務・戦略的SWOT分析
    LendingClub Corporation (LC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • General Electric Company:戦略・SWOT・企業財務分析
    General Electric Company - Strategy, SWOT and Corporate Finance Report Summary General Electric Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Virgin Atlantic Airways Ltd:企業の戦略・SWOT・財務情報
    Virgin Atlantic Airways Ltd - Strategy, SWOT and Corporate Finance Report Summary Virgin Atlantic Airways Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Levi Strauss & Co.:企業の戦略・SWOT・財務情報
    Levi Strauss & Co. - Strategy, SWOT and Corporate Finance Report Summary Levi Strauss & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Enlivant Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Enlivant Inc (Enlivant) is an assisted living facilities provider that offers senior living residence services. The center provides senior housing options, choosing assisted living and short term stay services. It also provides attentive and individualized care services. Enlivant offers assi …
  • Sodexo Inc:企業の戦略的SWOT分析
    Sodexo Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Pilot Energy Ltd (PGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Pilot Energy Ltd (Pilot), formerly Rampart Energy Ltd is an oil and gas exploration and production company. The company acquires, explores and develops conventional oil and gas assets in Australia. Its projects include Australia EP416 and EP480, Australia WA-507-P, Australia WA-503-P and Aus …
  • Medical Facilities Corp (DR):製薬・医療:M&Aディール及び事業提携情報
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • Reliance Steel & Aluminum Co:戦略・SWOT・企業財務分析
    Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • UGI Corp (UGI):企業の財務・戦略的SWOT分析
    UGI Corp (UGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Compania Minera Autlan SAB de CV:企業の戦略・SWOT・財務情報
    Compania Minera Autlan SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Compania Minera Autlan SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Total Energy Services Inc. (TOT)-石油・ガス分野:企業M&A・提携分析
    Summary Total Energy Services Inc. (Total Energy) is an energy services company. It offers contract drilling services and rental and transportation services for equipment utilized in drilling, completion and production activities in oil and gas wells. The company also provides fabrication, sale, ren …
  • Invacare Corporation (IVC):企業の財務・戦略的SWOT分析
    Invacare Corporation (IVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Kawasaki Heavy Industries, Ltd.:企業の戦略・SWOT・財務分析
    Kawasaki Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kawasaki Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆